FGFR4 and cardiomyopathy: We provide genetic and biochemical evidence that dysregulation of Fgfr4, Hras and Map2k2 in the heart of Rreb1 heterozygous mice is deleterious leading to a cardiomyopathy that is reminiscent of the phenotype observed in Noonan-like RASopathies.